Missing Cells-A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases
Abstract
Objective: Dengue cases in pregnancy have high morbidity and mortality. More so if it leads to immune thrombocytopenic purpura which causes a drastic decrease in platelet, increasing chances of bleeding and mortality and pregnancy itself being a state of hemodynamic instability.
Case report: Here, we present a case of dengue causing secondary immune thrombocytopenia. Managing these cases is challenging and need a multidisciplinary approach and should be done at a higher center. In previous reports, thrombocytopenia in such cases responded to steroids or IVIG. But in our case patient did not respond to either of them but to Romiplostim. There are only a few studies on the use of Romiplostim in dengue and dengue induced ITP and more study is required.
Conclusion: Dengue induced persistent thrombocytopenia is rare but should always be kept in mind in managing these cases.
2. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.
3. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93.
4. Neunert CE, Buchanan GR, Blanchette V, Barnard D, Young NL, Curtis C, Klaassen RJ. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2009;53(4):652-4.
5. Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, et al. Severe bleeding events in adults and
children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015;13(3):457-64.
6. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, et al.; Intercontinental Childhood ITP Study Group Registry II Participants. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112(10):4003-8.
7. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511-21.
8. Matzdorff A, Meyer O, Ostermann H, Kiefel V, Eberl W, Kühne T, et al. Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI. Oncol Res Treat. 2018; (Suppl. 5): 1–30.
9. Bussel JB, Soff G, Balduzzi A, Cooper N, Lawrence T, Semple JW. A Review of Romiplostim Mechanism of Action and Clinical Applicability. Drug Des Devel Ther. 2021;15:2243-2268.
10. Ramírez-Fonseca T, Segarra-Torres A, Jaume-Anselmi F, Ramírez-Rivera J. Dengue Fever: A Rare Cause of Immune Thrombocytopenia. Bol Asoc Med P R. 2015;107(2):51-3.
11. Thadchanamoorthy V, Dayasiri K. Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura-a pediatric case report. Trop Med Health. 2020; 48 (1): 59.
12. Kumar P, Charaniya R, Ghosh A, Sahoo R. Intravenous Immunoglobulin Responsive Persistent Thrombocytopenia after Dengue Haemorrhagic Fever. J Clin Diagn Res. 2016;10(4):OD10-1.
13. Rodríguez-Mejorada SM, Rosel-Gómez CG, Rosado-Castro RA, Domingo-Padilla MA, Ruiz-Delgado GJ. Romiplostim reverts the thrombocytopenia in dengue hemorrhagic fever. Hematol Oncol Stem Cell Ther. 2011;4(1):48-9.
Files | ||
Issue | Vol 17, No 2 (June 2023) | |
Section | Case Reports | |
DOI | https://doi.org/10.18502/jfrh.v17i2.12874 | |
Keywords | ||
Dengue Immune Thrombocytopenic Purpura Romiplostim Pregnancy Thrombocytopenia Steroids |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |